Evidence map›Paper›PMID 32621976›Full record

ArticleRegulatory toxicology and pharmacology : RTP2020

Skin sensitization in silico protocol.

Candice Johnson, Ernst Ahlberg, Lennart T Anger, Lisa Beilke, Romualdo Benigni, Joel Bercu, Sol Bobst, David Bower, Alessandro Brigo, Sarah Campbell and 45 more

Abstract read
In one paragraph

Article in Regulatory toxicology and pharmacology : RTP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Evaluating Pharmacokinetics and Toxicity of Potential Therapeutics Against Enterococcus faecalis in Endodontic Pathologies.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Heliyon · 2024
    Article
  11. Article
  12. Principles and Procedures for Assessment of Acute Toxicity IncorporatingComputational toxicology (Amsterdam, Netherlands) · 2022
    Article
  13. Article
  14. Implementation ofComputational toxicology (Amsterdam, Netherlands) · 2022
    Article
  15. Evaluating Confidence in Toxicity Assessments Based on Experimental Data andComputational toxicology (Amsterdam, Netherlands) · 2022
    Article
  16. Implementation of In Silico Toxicology Protocols in Leadscope.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  17. In Silico Models for Skin Sensitization and Irritation.Methods in molecular biology (Clifton, N.J.) · 2022
    Review
  18. Computational toxicology (Amsterdam, Netherlands) · 2021
    Article
  19. Computational toxicology (Amsterdam, Netherlands) · 2021
    Article
  20. Computational toxicology (Amsterdam, Netherlands) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

55 authors.

Candice JohnsonLeadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA. Electronic address: cjohnson@leadscope.com.
Ernst AhlbergBioinformatics Department, The University of Uppsala, 752 36, Uppsala, Sweden.
Lennart T AngerGenentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Lisa BeilkeToxicology Solutions Inc., San Diego, CA, USA.
Romualdo BenigniAlpha-PreTox, Via G.Pascoli 1, 00184, Roma, Italy.
Joel BercuGilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.
Sol BobstToxsci Advisors LLC, 2016 Main Suite 1901, Houston, TX, USA.
David BowerLeadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.
Alessandro BrigoRoche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
Sarah CampbellNelson Laboratories, LLC, 6280 South Redwood Road, Salt Lake City, UT, 84123, USA.
Mark T D CroninSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK.
Ian CrooksBritish American Tobacco, Research and Development, Regents Park Road, Southampton, Hampshire, SO15 8TL, UK.
Kevin P CrossLeadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.
Tatyana DoktorovaEdelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.
Thomas ExnerEdelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.
David FaulknerChemical Sciences Division, Lawrence Berkeley National Lab, USA.
Ian M FearonwhatIF? Consulting Ltd, The Crispin Burr Street, Harwell, OX11 0DT, UK.
Markus FehrDSM Nutritional Products, Kaiseraugst, Switzerland.
Shayne C GadGad Consulting Services, 4008 Barrett Drive, Suite 201, Raleigh, NC, 27609, USA.
Véronique GervaisServier Group, 905 Route de Saran, 45520, Gidy, France.
Amanda GiddingsGlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.
Susanne GlowienkeNovartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.
Barry HardyEdelweiss Connect GmbH, Technology Park Basel, Hochbergerstrasse 60C, CH-4057, Basel / Basel-Stadt, Switzerland.
Catrin HasselgrenGenentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Jedd HillegassBristol-Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.
Robert JollyToxicology Division, Eli Lilly and Company, Indianapolis, IN, USA.
Eckart KruppSanofi, Corporate HSE, Global Product Steweardship, Industriepark Hoechst, D-65926, Frankfurt Am Main, Germany.
Liat LomnitskiPerrigo Israel Pharmaceuticals Ltd, Shoham, Israel.
Jason MagbyColgate-Palmolive Technology Center, 909 River Road, Piscataway, NJ, 08855, USA.
Jordi MestresIMIM Hospital Del Mar Institute of Medical Research and University Pompeu Fabra, Doctor Aiguader 88, Parc de Recerca Biomèdica, 08003 Barcelona, Spain; and Chemotargets SL, Baldiri Reixac 4, Parc Científic de Barcelona, 08028, Barcelona, Spain.
Lawrence Milchak3M Company, St. Paul, MN, USA.
Scott MillerLeadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.
Wolfgang MusterRoche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
Louise NeilsonBroughton Nicotine Services, Oak Tree House, West Craven Drive, Earby, Lancashire, BB18 6JZ, UK.
Rahul ParakhiaChurch & Dwight Co., Inc, 469 North Harrison Street, Princeton, NJ, 08543, USA.
Alexis ParentyNovartis Pharma AG, Pre-Clinical Safety, Werk Klybeck, CH-4057, Basel, Switzerland.
Patricia ParrisPfizer Worldwide Research and Development, Sandwich, UK.
Alexandre PaulinoORO AGRI Europe, S.A, Palmela, Portugal.
Ana Theresa PaulinoORO AGRI Europe, S.A, Palmela, Portugal.
David W RobertsNelson Laboratories, LLC, 6280 South Redwood Road, Salt Lake City, UT, 84123, USA.
Harald SchleckerBayer AG, Research & Development, Pharmaceuticals, Industrial Chemicals Toxicology & Genetic Toxicology, 42096, Wuppertal, Germany.
Reinhard StidlSafetree Consulting e.U, Vienna, Austria.
Diana Suarez-RodrigezFStox Consulting LTD, 2 Brooks Road, Raunds, Wellingborough, NN9 6NS, UK.
David T SzaboPPG Industries, Pittsburgh, PA, 15146, USA.
Raymond R TiceRTice Consulting, Hillsborough, NC, 27278, USA.
Daniel UrbischBASF SE, Product Safety, Carl-Bosch-Strasse 38, 67056, Ludwigshafen Am Rhein, Germany.
Anna VuorinenDSM Nutritional Products, Kaiseraugst, Switzerland.
Brian WallColgate-Palmolive Technology Center, 909 River Road, Piscataway, NJ, 08855, USA.
Thibaud WeilerServier Group, 905 Route de Saran, 45520, Gidy, France.
Angela T WhiteGlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.
Jessica WhritenourPfizer Inc., Drug Safety Research and Development, Eastern Point Road, Groton, CT, 06340, USA.
Joerg WichardBayer AG, Research & Development, Pharmaceuticals, Industrial Chemicals Toxicology & Genetic Toxicology, 42096, Wuppertal, Germany.
David WoolleyForthTox Limited, PO Box 13550, Linlithgow, EH49 7YU, UK.
Craig ZwicklTransendix LLC, 1407 Moores Manor, Indianapolis, IN, 46229, USA.
Glenn J MyattLeadscope, Inc, 1393 Dublin Rd, Columbus, OH, 43215, USA.

Funding

Rapid response toxicology prediction platformR44ES026909 · NIEHS · LEADSCOPE, INC. · PI MYATT, GLENN JOHN · 2018 to 2019
$1000k
Rapid response toxicology prediction platformR43ES026909 · NIEHS · LEADSCOPE, INC. · PI MYATT, GLENN JOHN · 2016 to 2016
$149k
NIEHS NIH HHS R43 ES026909NIEHS NIH HHS R44 ES026909
6 · The paper itself

Abstract

The assessment of skin sensitization has evolved over the past few years to include in vitro assessments of key events along the adverse outcome pathway and opportunistically capitalize on the strengths of in silico methods to support a weight of evidence assessment without conducting a test in animals. While in silico methods vary greatly in their purpose and format; there is a need to standardize the underlying principles on which such models are developed and to make transparent the implications for the uncertainty in the overall assessment. In this contribution, the relationship between skin sensitization relevant effects, mechanisms, and endpoints are built into a hazard assessment framework. Based on the relevance of the mechanisms and effects as well as the strengths and limitations of the experimental systems used to identify them, rules and principles are defined for deriving skin sensitization in silico assessments. Further, the assignments of reliability and confidence scores that reflect the overall strength of the assessment are discussed. This skin sensitization protocol supports the implementation and acceptance of in silico approaches for the prediction of skin sensitization.

Indexed as

AllergensAnimalsAnimal Testing AlternativesComputer SimulationDendritic CellsDermatitis, ContactHaptensHumansKeratinocytesLymphocytesRisk AssessmentAllergensHaptensComputational toxicologyComputational toxicology protocolsDefined approachExpert alertsExpert reviewExtractables and leachablesIn silicoIn silico toxicologyIntegrated approaches to testing and assessment (IATA)(Q)SARSkin sensitization

Identifiers

PMID32621976
PMCPMC7518315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.